HighTower Advisors
LAB icon

HighTower Advisors’s Standard BioTools LAB Stock Holding History

HighTower Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Buy
355,581
+301,090
+553% +$285K ﹤0.01% 3236
2026
Q1 		$50.1K Buy
54,491
+1,700
+3% +$2.06K ﹤0.01% 3707
2025
Q4 		$67.6K Hold
52,791
– – ﹤0.01% 3553
2025
Q3 		$68.6K Sell
52,791
-171,422
-76% -$225K ﹤0.01% 3587
2025
Q2 		$269K Buy
224,213
+121,422
+118% +$135K ﹤0.01% 3029
2025
Q1 		$111K Buy
102,791
+10,000
+11% +$14K ﹤0.01% 3339
2024
Q4 		$162K Buy
92,791
+10,690
+13% +$19.9K ﹤0.01% 3257
2024
Q3 		$160K Sell
82,101
-6,000
-7% -$11.8K ﹤0.01% 3203
2024
Q2 		$157K Buy
88,101
+12,000
+16% +$29.3K ﹤0.01% 3095
2024
Q1 		$206K Sell
76,101
-116,569
-61% -$281K ﹤0.01% 2965
2023
Q4 		$426K Hold
192,670
– – ﹤0.01% 2436
2023
Q3 		$559K Sell
192,670
-593,616
-75% -$1.55M ﹤0.01% 2159
2023
Q2 		$1.52M Sell
786,286
-206,233
-21% -$407K ﹤0.01% 1513
2023
Q1 		$1.94M Buy
992,519
+536,341
+118% +$1.06M ﹤0.01% 1302
2022
Q4 		$534K Buy
456,178
+208,931
+85% +$257K ﹤0.01% 2092
2022
Q3 		$272K Sell
247,247
-88,824
-26% -$134K ﹤0.01% 2408
2022
Q2 		$538K Buy
336,071
+145,683
+77% +$360K ﹤0.01% 2005
2022
Q1 		$683K Sell
190,388
-1,242
-0.6% -$4.29K ﹤0.01% 1978
2021
Q4 		$751K Buy
+191,630
New +$897K ﹤0.01% 1919

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

HighTower Advisors's LAB Position: Q2 2026 in Review

HighTower Advisors increased its Standard BioTools (LAB) stake by 553% in Q2 2026, buying an estimated $285K and bringing the position to 355,581 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #3236.

HighTower Advisors first reported a position in LAB in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.94M in Q1 2023. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • HighTower Advisors held 355,581 shares of Standard BioTools worth $293K as of Q2 2026.
  • HighTower Advisors bought 301,090 Standard BioTools shares in Q2 2026, an estimated $285K.
  • Standard BioTools made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3236 holding.
  • HighTower Advisors first reported a position in Standard BioTools in Q4 2021 and has held it in 19 quarters since.
  • HighTower Advisors's Standard BioTools position peaked at $1.94M in Q1 2023.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.